These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31202462)
41. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression. Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266 [TBL] [Abstract][Full Text] [Related]
42. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Nairismägi ML; Vislovukh A; Meng Q; Kratassiouk G; Beldiman C; Petretich M; Groisman R; Füchtbauer EM; Harel-Bellan A; Groisman I Oncogene; 2012 Nov; 31(47):4960-6. PubMed ID: 22266852 [TBL] [Abstract][Full Text] [Related]
43. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition. Nam EH; Lee Y; Moon B; Lee JW; Kim S Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770 [TBL] [Abstract][Full Text] [Related]
44. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1. Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001 [TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth. Takeuchi A; Shiota M; Beraldi E; Thaper D; Takahara K; Ibuki N; Pollak M; Cox ME; Naito S; Gleave ME; Zoubeidi A Mol Cell Endocrinol; 2014 Mar; 384(1-2):117-25. PubMed ID: 24491388 [TBL] [Abstract][Full Text] [Related]
46. Breast tumor cell-specific knockout of Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077 [TBL] [Abstract][Full Text] [Related]
47. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation. Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968 [TBL] [Abstract][Full Text] [Related]
48. AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment. Qu S; Jia W; Nie Y; Shi W; Chen C; Zhao Z; Song W Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062458 [TBL] [Abstract][Full Text] [Related]
49. Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation. Maurel M; Obacz J; Avril T; Ding YP; Papadodima O; Treton X; Daniel F; Pilalis E; Hörberg J; Hou W; Beauchamp MC; Tourneur-Marsille J; Cazals-Hatem D; Sommerova L; Samali A; Tavernier J; Hrstka R; Dupont A; Fessart D; Delom F; Fernandez-Zapico ME; Jansen G; Eriksson LA; Thomas DY; Jerome-Majewska L; Hupp T; Chatziioannou A; Chevet E; Ogier-Denis E EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31040128 [TBL] [Abstract][Full Text] [Related]
50. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer. Wang QS; Kong PZ; Li XQ; Yang F; Feng YM Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863 [TBL] [Abstract][Full Text] [Related]
51. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer. Liang Y; Hu J; Li J; Liu Y; Yu J; Zhuang X; Mu L; Kong X; Hong D; Yang Q; Hu G Cancer Res; 2015 Sep; 75(17):3672-80. PubMed ID: 26141861 [TBL] [Abstract][Full Text] [Related]
52. Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape. Maarouf A; Boissard A; Henry C; Leman G; Coqueret O; Guette C; Lelièvre E Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913074 [TBL] [Abstract][Full Text] [Related]
53. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797 [TBL] [Abstract][Full Text] [Related]
54. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. Chen SY; Teng SC; Cheng TH; Wu KJ Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472 [TBL] [Abstract][Full Text] [Related]
55. Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer. Kereh DS; Pieter J; Hamdani W; Haryasena H; Sampepajung D; Prihantono P Breast Dis; 2021; 40(S1):S103-S107. PubMed ID: 34092584 [TBL] [Abstract][Full Text] [Related]
56. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1. Cao C; Sun D; Zhang L; Song L Oncotarget; 2016 Nov; 7(48):79956-79963. PubMed ID: 27835599 [TBL] [Abstract][Full Text] [Related]
57. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076 [TBL] [Abstract][Full Text] [Related]
58. Cancer-secreted AGR2 induces programmed cell death in normal cells. Vitello EA; Quek SI; Kincaid H; Fuchs T; Crichton DJ; Troisch P; Liu AY Oncotarget; 2016 Aug; 7(31):49425-49434. PubMed ID: 27283903 [TBL] [Abstract][Full Text] [Related]
59. MiR-543 functions as tumor suppressor in ovarian cancer by targeting TWIST1. Yu Q; Zhang Z; He B; Wang H; Shi P; Li Y J Biol Regul Homeost Agents; 2020; 34(1):101-110. PubMed ID: 32148011 [TBL] [Abstract][Full Text] [Related]
60. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]